MEDICAMEQ.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	368 888
Gjennomsnittsvolum	43 152.00
Markedsverdi	7.38B
EPS	INR0 ( 2024-02-11 )
Neste inntjeningsdato	( INR0 ) 2024-05-27
Last Dividend	INR1.000 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	64.49
ATR14	INR0 (0.00%)

Volum Korrelasjon

Lang: 0.00 (neutral)

Kort: 0.00 (neutral)

Signal:(74.853) Neutral

Medicamen Biotech Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Medicamen Biotech Limited Korrelasjon - Valuta/Råvare

0.00
( neutral )

0.60
( weak )

0.00
( neutral )

Medicamen Biotech Limited Økonomi

Annual	2022
Omsetning:	INR1.41B
Bruttogevinst:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Omsetning:	INR1.41B
Bruttogevinst:	INR687.74M (48.82 %)
EPS:	INR11.92

FY	2022
Omsetning:	INR1.15B
Bruttogevinst:	INR479.88M (41.57 %)
EPS:	INR12.19

FY	2021
Omsetning:	INR1.13B
Bruttogevinst:	INR335.16M (29.74 %)
EPS:	INR9.93

Financial Reports:

No articles found.

Medicamen Biotech Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Medicamen Biotech Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.57 - low (18.86%) | Divividend Growth Potential Score: 2.46 - Decrease likely (50.82%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2022-09-19
Last Dividend	INR1.000	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.02%	--
Score	1.43	--
Div. Sustainability Score	3.57
Div.Growth Potential Score	2.46
Div. Directional Score	3.02	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR1.000	0.10%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RBLBANK.NS	Dividend Junior	2023-08-18	Sporadic	8	0.25%
KOVAI.NS	Dividend Junior	2023-08-10	Annually	4	0.17%
EXIDEIND.NS	Dividend Junior	2023-08-01	Annually	22	0.76%
AMIORG.NS	Dividend Junior	2023-09-18	Annually	3	0.15%
TALBROAUTO.NS	Dividend Junior	2023-09-15	Annually	18	0.48%
NGIL.NS	No Dividend Player	2023-09-21	Annually	4	0.08%
IGPL.NS	Dividend Junior	2023-08-17	Sporadic	18	1.12%
CHEMFAB.NS	Dividend Junior	2023-08-22	Sporadic	7	0.32%
SAKSOFT.NS	Dividend Junior	2023-08-07	Semi-Annually	20	0.56%
LUMAXIND.NS	Dividend Junior	2023-08-10	Annually	23	1.26%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0671	1.500	8.66	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0582	1.500	-0.464	-0.696	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	5.27	1.000	9.16	9.16	[3 - 30]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	10.97	2.00	4.51	9.03	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.469	1.000	5.52	5.52	[0.2 - 0.8]
operatingProfitMarginTTM	0.104	1.000	9.92	9.92	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.57

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	63.35	1.000	3.70	0	[1 - 100]
returnOnEquityTTM	0.0582	2.50	-0.298	-0.696	[0.1 - 1.5]
freeCashFlowPerShareTTM	10.97	2.00	6.34	9.03	[0 - 30]
dividendYielPercentageTTM	0.174	1.500	5.64	0	[0 - 0.4]
operatingCashFlowPerShareTTM	10.97	2.00	6.34	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.136	1.500	-4.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0814	1.000	-0.466	0	[0.1 - 0.5]
Total Score				2.46

Medicamen Biotech Limited

Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delhi, India.